Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.644, 2012-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Standard chemo plus docetaxel does not compromise QOL
Inpharma, Vol. 1, Iss. 1563, 2006-01 ,pp. :
Access to resources
Recommend
Doxorubicin + docetaxel vs standard chemo in breast cancer
Inpharma, Vol. 1, Iss. 1512, 2005-01 ,pp. :
Arterial thrombosis risk raised during induction chemo for MM
Reactions Weekly, Vol. 1, Iss. 1317, 2010-01 ,pp. :
Cetuximab an EXTREMEly important addition in SCCHN
Inpharma, Vol. 1, Iss. 1592, 2007-01 ,pp. :